VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $870,000 | +46.0% | 37,438 | -0.1% | 0.00% | +33.3% |
Q1 2018 | $596,000 | -60.6% | 37,466 | -48.6% | 0.00% | -66.7% |
Q4 2017 | $1,514,000 | +42.6% | 72,843 | -1.7% | 0.01% | +28.6% |
Q3 2017 | $1,062,000 | -20.1% | 74,106 | -3.5% | 0.01% | -22.2% |
Q2 2017 | $1,329,000 | +190.8% | 76,792 | +85.4% | 0.01% | +200.0% |
Q1 2017 | $457,000 | +22.5% | 41,414 | +61.2% | 0.00% | 0.0% |
Q4 2016 | $373,000 | +0.5% | 25,695 | +70.2% | 0.00% | 0.0% |
Q3 2016 | $371,000 | +52.0% | 15,094 | +24.7% | 0.00% | +50.0% |
Q2 2016 | $244,000 | -88.7% | 12,107 | -43.0% | 0.00% | -92.0% |
Q4 2015 | $2,160,000 | -20.2% | 21,250 | +40.1% | 0.02% | -44.4% |
Q3 2015 | $2,706,000 | +152.4% | 15,170 | +21.8% | 0.04% | +45.2% |
Q2 2013 | $1,072,000 | – | 12,457 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |